Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 May;64(5):1589–1594. doi: 10.1128/iai.64.5.1589-1594.1996

Molecular composition of Clostridium botulinum type A progenitor toxins.

K Inoue 1, Y Fujinaga 1, T Watanabe 1, T Ohyama 1, K Takeshi 1, K Moriishi 1, H Nakajima 1, K Inoue 1, K Oguma 1
PMCID: PMC173966  PMID: 8613365

Abstract

The molecular composition of progenitor toxins produced by a Clostridium botulinum type A strain (A-NIH) was analyzed. The strain produced three types of progenitor toxins (19 S, 16 S, and 12 S) as reported previously. Purified 19 S and 16 S toxins demonstrated the same banding profiles on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), indicating that they consist of the same protein components. The nontoxic components of the 19 S and 16 S toxins are a nontoxic non-hemagglutinin (HA) (molecular mass, 120 kDa) and HA. HA could be fractionated into five subcomponents with molecular masses of 52, 35, 20, 19, and 15 kDa in the presence of 2-mercaptoethanol. The molar ratios of neurotoxins, nontoxic non-HAs, and each HA subcomponent of the 19 S and 16 S toxins showed that only HA-35 of the 19 S toxin was approximately twice the size of that of the 16 S toxin, suggesting that the 19 S toxin is a dimer of the 16 S toxin cross-linked by the 35-kDa subcomponent. The nontoxic non-HA of the 12 S toxin, but not those of the 19 S and 16 S toxins, demonstrated two bands with molecular masses of 106 and 13 kDa on SDS-PAGE with or without 2-mercaptoethanol. It was concluded from the N-terminal amino acid sequences that 106- and 13-kDa proteins were generated by a cleavage of whole nontoxic non-HA. This may explain why the 12 S and 16 S (and 19 S) toxins exist in the same culture. We also found that the HA and its 35-kDa subcomponent exist in a free state in the culture fluid along with three types of progenitor toxins.

Full Text

The Full Text of this article is available as a PDF (362.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binz T., Kurazono H., Wille M., Frevert J., Wernars K., Niemann H. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J Biol Chem. 1990 Jun 5;265(16):9153–9158. [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. DasGupta B. R., Dekleva M. L. Botulinum neurotoxin type A: sequence of amino acids at the N-terminus and around the nicking site. Biochimie. 1990 Sep;72(9):661–664. doi: 10.1016/0300-9084(90)90048-l. [DOI] [PubMed] [Google Scholar]
  4. DasGupta B. R., Sugiyama H. A common subunit structure in Clostridium botulinum type A, B and E toxins. Biochem Biophys Res Commun. 1972 Jul 11;48(1):108–112. doi: 10.1016/0006-291x(72)90350-6. [DOI] [PubMed] [Google Scholar]
  5. Fujinaga Y., Inoue K., Shimazaki S., Tomochika K., Tsuzuki K., Fujii N., Watanabe T., Ohyama T., Takeshi K., Inoue K. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization. Biochem Biophys Res Commun. 1994 Dec 15;205(2):1291–1298. doi: 10.1006/bbrc.1994.2805. [DOI] [PubMed] [Google Scholar]
  6. Fujita R., Fujinaga Y., Inoue K., Nakajima H., Kumon H., Oguma K. Molecular characterization of two forms of nontoxic-nonhemagglutinin components of Clostridium botulinum type A progenitor toxins. FEBS Lett. 1995 Nov 27;376(1-2):41–44. doi: 10.1016/0014-5793(95)01241-5. [DOI] [PubMed] [Google Scholar]
  7. Hirano H., Watanabe T. Microsequencing of proteins electrotransferred onto immobilizing matrices from polyacrylamide gel electrophoresis: application to an insoluble protein. Electrophoresis. 1990 Jul;11(7):573–580. doi: 10.1002/elps.1150110708. [DOI] [PubMed] [Google Scholar]
  8. Kimura K., Fujii N., Tsuzuki K., Murakami T., Indoh T., Yokosawa N., Takeshi K., Syuto B., Oguma K. The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome. Biochem Biophys Res Commun. 1990 Sep 28;171(3):1304–1311. doi: 10.1016/0006-291x(90)90828-b. [DOI] [PubMed] [Google Scholar]
  9. Oguma K., Syuto B., Iida H., Kubo S. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Infect Immun. 1980 Dec;30(3):656–660. doi: 10.1128/iai.30.3.656-660.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ohyama T., Watanabe T., Fujinaga Y., Inoue K., Sunagawa H., Fujii N., Inoue K., Oguma K. Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16. Microbiol Immunol. 1995;39(7):457–465. doi: 10.1111/j.1348-0421.1995.tb02229.x. [DOI] [PubMed] [Google Scholar]
  11. STERNE M., WENTZEL L. M. A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D. J Immunol. 1950 Aug;65(2):175–183. [PubMed] [Google Scholar]
  12. Somers E., DasGupta B. R. Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes? J Protein Chem. 1991 Aug;10(4):415–425. doi: 10.1007/BF01025256. [DOI] [PubMed] [Google Scholar]
  13. Sugii S., Sakaguchi G. Molecular construction of Clostridium botulinum type A toxins. Infect Immun. 1975 Dec;12(6):1262–1270. doi: 10.1128/iai.12.6.1262-1270.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Syuto B., Kubo S. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution. J Biol Chem. 1981 Apr 25;256(8):3712–3717. [PubMed] [Google Scholar]
  15. Thompson D. E., Brehm J. K., Oultram J. D., Swinfield T. J., Shone C. C., Atkinson T., Melling J., Minton N. P. The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem. 1990 Apr 20;189(1):73–81. doi: 10.1111/j.1432-1033.1990.tb15461.x. [DOI] [PubMed] [Google Scholar]
  16. Tsuzuki K., Kimura K., Fujii N., Yokosawa N., Indoh T., Murakami T., Oguma K. Cloning and complete nucleotide sequence of the gene for the main component of hemagglutinin produced by Clostridium botulinum type C. Infect Immun. 1990 Oct;58(10):3173–3177. doi: 10.1128/iai.58.10.3173-3177.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tsuzuki K., Kimura K., Fujii N., Yokosawa N., Oguma K. The complete nucleotide sequence of the gene coding for the nontoxic-nonhemagglutinin component of Clostridium botulinum type C progenitor toxin. Biochem Biophys Res Commun. 1992 Mar 31;183(3):1273–1279. doi: 10.1016/s0006-291x(05)80328-6. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES